RNA logo

RNAAtrium Therapeutics Inc.

$11.80
$0.50
(4.07%)
Today
Closed $11.80
$0.19
(1.61%)
After Hours
Updated: 06:58 PM EDT
Mkt Cap$210.4M
Vol209,488.00

About

Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need. The company was founded on September 30, 2025 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Atrium Therapeutics Inc.?
What is the 52-week high for Atrium Therapeutics Inc.?
What is the 52-week low for Atrium Therapeutics Inc.?
What is Atrium Therapeutics Inc. stock price today?
What was Atrium Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of Atrium Therapeutics Inc.?
What is the 50-day moving average of Atrium Therapeutics Inc.?

Advertisement|Remove ads.